Nutriband To Present at the Noble Capital Markets’ Emerging Growth Virtual Equity Conference
Nutriband (NASDAQ: NTRB / NTRBW) will present at the Noble Capital Markets Emerging Growth Virtual Equity Conference on October 8, 2025. Chairman Serguei Melnik will deliver a formal presentation including a fireside Q&A at 3:00 PM Eastern, with live questions from the virtual audience.
Registered, qualified investors may request scheduled 1x1 meetings with management by contacting Giorgia Pigato at Noble Capital Markets. The live webcast will be available via Channelchek and will be archived on the company website and Channelchek for 90 days. Registration for the live presentation is free for attendees.
Nutriband (NASDAQ: NTRB / NTRBW) si presenterà alla Noble Capital Markets Emerging Growth Virtual Equity Conference l' 8 ottobre 2025. Il presidente Serguei Melnik terrà una presentazione formale che includerà una sessione di domande e risposte in stile informale al camino (fireside Q&A) alle 15:00 ora orientale, con domande in diretta dal pubblico virtuale.
Investitori registrati e qualificati possono richiedere incontri individuali 1x1 programmati con il management contattando Giorgia Pigato presso Noble Capital Markets. La trasmissione in diretta sarà disponibile via Channelchek e sarà archiviata sul sito dell'azienda e su Channelchek per 90 giorni. La registrazione per la presentazione in diretta è gratuita per i partecipanti.
Nutriband (NASDAQ: NTRB / NTRBW) se presentará en la Noble Capital Markets Emerging Growth Virtual Equity Conference el 8 de octubre de 2025. El presidente Serguei Melnik ofrecerá una presentación formal que incluirá una charla informal con preguntas y respuestas a las 3:00 p.m. hora del Este, con preguntas en directo del público virtual.
Los inversores registrados y cualificados pueden solicitar reuniones 1x1 programadas con la dirección contactando a Giorgia Pigato en Noble Capital Markets. La transmisión en directo estará disponible vía Channelchek y se archivará en la página de la empresa y Channelchek durante 90 días. El registro para la presentación en directo es gratuito para los asistentes.
Nutriband (NASDAQ: NTRB / NTRBW) 은 2025년 10월 8일에 열리는 Noble Capital Markets Emerging Growth Virtual Equity Conference 에 발표할 예정입니다. 의장 Serguei Melnik 은 동부 표준시 3:00 PM에 fireside Q&A 를 포함한 공식 발표를 진행하며, 온라인 청중의 실시간 질문을 받습니다.
등록된 자격 보유 투자자들은 Noble Capital Markets 의 Giorgia Pigato 에 연락하여 경영진과의 1 대 1 맞춤 미팅을 예약할 수 있습니다. 라이브 웹캐스트는 Channelchek 을 통해 시청 가능하며 회사 웹사이트 및 Channelchek 에 90일간 보관됩니다. 라이브 발표 등록은 참석자에 한해 무료입니다.
Nutriband (NASDAQ: NTRB / NTRBW) se présentera lors de la Noble Capital Markets Emerging Growth Virtual Equity Conference le 8 octobre 2025. Le président Serguei Melnik effectuera une présentation formelle incluant une séance de questions-réponses au coin du feu à 15h00, heure de l'Est, avec des questions en direct du public virtuel.
Les investisseurs enregistrés et qualifiés peuvent demander des rencontres individuelles 1x1 programmées avec la direction en contactant Giorgia Pigato chez Noble Capital Markets. La webdiffusion en direct sera disponible via Channelchek et sera archivée sur le site de l'entreprise et Channelchek pendant 90 jours. L'inscription à la présentation en direct est gratuite pour les participants.
Nutriband (NASDAQ: NTRB / NTRBW) wird am 8. Oktober 2025 bei der Noble Capital Markets Emerging Growth Virtual Equity Conference präsentieren. Vorsitzender Serguei Melnik wird eine formelle Präsentation halten, einschließlich einer fireside Q&A-Sitzung um 15:00 Uhr Eastern, mit Live-Fragen aus dem virtuellen Publikum.
Registrierte, qualifizierte Investoren können bei Noble Capital Markets Giorgia Pigato kontaktieren, um geplante 1x1-Treffen mit dem Management zu vereinbaren. Der Live-Webcast ist über Channelchek verfügbar und wird auf der Unternehmenswebsite und Channelchek für 90 Tage archiviert. Die Registrierung für die Live-Präsentation ist für Teilnehmer kostenlos.
Nutriband (NASDAQ: NTRB / NTRBW) ستشارك في مؤتمر Noble Capital Markets Emerging Growth Virtual Equity Conference في 8 أكتوبر 2025. سيقدم الرئيس Serguei Melnik عرضاً رسمياً يتضمن جلسة أسئلة وأجوبة بجانب الموقد عند الساعة 3:00 مساءً بتوقيت الساحل الشرقي، مع أسئلة مباشرة من الجمهور الافتراضي.
يمكن للمستثمرين المسجلين والمؤهلين طلب ترتيب لقاءات 1x1 مع الإدارة من خلال الاتصال بـ Giorgia Pigato في Noble Capital Markets. ستتوفر البث المباشر عبر Channelchek وسيتم أرشفته على موقع الشركة وعبر Channelchek لمدة 90 يوماً. التسجيل للحضور مجاني للمشاركين.
Nutriband (NASDAQ: NTRB / NTRBW) 将在 Noble Capital Markets Emerging Growth Virtual Equity Conference 于 2025年10月8日 进行演讲。董事长 Serguei Melnik 将进行正式演讲，包括在 东部时间下午3:00 的炉边问答环节，与虚拟观众的实时提问互动。
已注册、合格的投资者可以通过联系 Noble Capital Markets 的 Giorgia Pigato 安排与管理层的 1 对 1 会谈。直播 webcast 将通过 Channelchek 提供，并将在公司网站和 Channelchek 上归档 90 天。参加现场演讲的注册对参与者免费。
- None.
- None.
ORLANDO, Fla., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW), today announced that its Chairman Serguei Melnik will present at Noble Capital Markets’ Emerging Growth Virtual Equity Conference on Wednesday, October 8 at 15:00 Eastern Standard Time. The formal presentation will feature a fireside style Q&A session with questions welcome from the live virtual audience. Scheduled 1x1 meetings with Mr. Melnik are also available for registered, qualified investor attendees.
Attendees interested in viewing the live presentation can register for this event at no cost, here: Virtual Equity Conference Registration
Qualified investors wishing to meet 1x1 with company management can reach out to Giorgia Pigato, from Noble Capital Markets, at gpigato@noblecapitalmarkets.com.
A video webcast of the presentation will be available as part of a complete catalog of presentations available on Channelchek www.channelchek.com, the investor portal created by Noble. The webcast will be archived on the company's website and on Channelchek.com for 90 days following the event.
About AVERSA™ Abuse-Deterrent Transdermal Technology
Nutriband's AVERSA™ abuse-deterrent transdermal technology incorporates aversive agents into transdermal patches to prevent the abuse, diversion, misuse, and accidental exposure of drugs with abuse potential. The AVERSA™ abuse-deterrent technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, including opioids and stimulant drugs, while making sure that these drugs remain accessible to those patients who really need them. The technology is covered by a broad intellectual property portfolio with patents granted in the United States, Europe, Japan, Korea, Russia, China, Canada, Mexico, and Australia.
About Nutriband Inc.
We are primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Our lead product under development is an abuse-deterrent fentanyl patch incorporating our AVERSA™ abuse-deterrent technology. AVERSA™ technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.
The Company's website is www.nutriband.com. Any material contained in or derived from the Company's websites or any other website is not part of this press release.
About Noble Capital Markets
Established in 1984, Noble Capital Markets is an SEC / FINRA registered full-service investment bank and advisory firm with an award-winning research team and proprietary investor distribution platform. We deliver middle market expertise to entrepreneurs, corporations, financial sponsors, and investors. Over the past 40 years, Noble has raised billions of dollars for companies and published more than 45,000 equity research reports.
About Channelchek
Noble launched www.channelchek.com in 2018 – an investor community dedicated exclusively to public emerging growth companies and their industries. Channelchek is the first service to offer institutional-quality research to the public, for FREE at every level without a subscription. More than 7,000 public emerging growth companies are listed on the site, and content including equity research, webcasts, and industry articles.
Forward-Looking Statements
Certain statements contained in this press release, including, without limitation, statements containing the words "believes," "anticipates," "expects" and words of similar import, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve both known and unknown risks and uncertainties. The Company's actual results may differ materially from those anticipated in its forward-looking statements as a result of a number of factors, including those including the Company's ability to develop its proposed abuse-deterrent fentanyl transdermal system and other proposed products, its ability to obtain patent protection for its abuse technology, its ability to obtain the necessary financing to develop products and conduct the necessary clinical testing, its ability to obtain Federal Food and Drug Administration approval to market any product it may develop in the United States and to obtain any other regulatory approval necessary to market any product in other countries, including countries in Europe, its ability to market any product it may develop, its ability to create, sustain, manage or forecast its growth; its ability to attract and retain key personnel; changes in the Company's business strategy or development plans; competition; business disruptions; adverse publicity and international, national and local general economic and market conditions and risks generally associated with an undercapitalized developing company, as well as the risks contained under "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the Company's Form S-1, Forms 10-K’s and Forms 10-Q’s, and the Company's other filings with the Securities and Exchange Commission. Except as required by applicable law, we undertake no obligation to revise or update any forward-looking statements to reflect any event or circumstance that may arise after the date hereof.
Contact Information:
Nutriband Inc.
Phone: 407-377-6695
Email: info@nutriband.com
SOURCE: Nutriband Inc.
FAQ
When will Nutriband (NTRB) present at the Noble Capital Markets virtual conference?
Who from Nutriband will present at the NTRB conference on October 8, 2025?
How can investors register to watch the Nutriband (NTRB) webcast on October 8, 2025?
Can qualified investors schedule 1x1 meetings with Nutriband management at the conference?
Where will the Nutriband (NTRB) webcast be available after the October 8, 2025 presentation?
